Transcriptional regulation of innate and adaptive lymphocyte lineages

Annual Review of Immunology

Volumn 33, Issue , 2015, Pages 607-642

  De Obaldia, Maria Elena ^a,b   Bhandoola, Avinash ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Enhancer regulation; Evolution of lymphocytes; Innate lymphoid cell development; Lineage commitment; T cell development; Transcription factors

Indexed keywords

E PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; NOTCH RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR BCL11B; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR GFI1; TRANSCRIPTION FACTOR NFIL3; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CELL FATE; CELL LINEAGE; CELL MATURATION; EFFECTOR CELL; ENHANCER REGION; HUMAN; INNATE IMMUNITY; INNATE LIKE T LYMPHOCYTE; INNATE LYMPHOID CELL; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; LYMPHOID PROGENITOR CELL; LYMPHOPOIESIS; NONHUMAN; NOTCH SIGNALING PATHWAY; PRE T LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; LYMPHOID PROGENITOR CELLS; TRANSCRIPTION, GENETIC;

EID: 84927655606     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032414-112032     Document Type: Article

References (313)

1. SpitsH,Cupedo T. 2012. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30:647-75
2. Lanier LL. 2013. Shades of grey-the blurring view of innate and adaptive immunity. Nat. Rev. Immunol. 13(2):73-74
3. Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, et al. 2012. Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 13(10):1000-9
4. Guo P, Hirano M, Herrin BR, Li J, Yu C, et al. 2009. Dual nature of the adaptive immune system in lampreys. Nature 459(7248):796-801
5. Hirano M, Guo P, McCurley N, Schorpp M, Das S, et al. 2013. Evolutionary implications of a third lymphocyte lineage in lampreys. Nature 501(7467):435-38
6. Spangrude GJ, Heimfeld S, Weissman IL. 1998. Purification and characterization of mouse hematopoietic stem cells. Science 241(4861):58-62
7. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1(8):661-73
8. Morrison SJ, Hemmati HD,Wandycz AM,Weissman IL. 1995. The purification and characterization of fetal liver hematopoietic stem cells. PNAS 92(22):10302-6
9. Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, Weissman IL. 2005. Differential expression of potential regulators in hematopoietic stem cells. PLOS Genet. 1(3):e28
10. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121(7):1109-21
11. Christensen JL, Weissman IL. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. PNAS 98(25):14541-46
12. Adolfsson J,Borge OJ, Bryder D, Theilgaard-M önch K, Astrand-Grundstr ömI, et al. 2001. Upregulation of Flt3 expression within the bone marrow Lin-Sca1+c-kit+ stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15(4):659-69
13. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91(5):661-72
14. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404(6774):193-97
15. Adolfsson J,ManssonR, Buza-Vidas N, Hultquist A, Liuba K, et al. 2005. Identification of Flt3+ lymphomyeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell 121(2):295-306
16. Lu M, Kawamoto H, Katsube Y, Ikawa T, Katsura Y. 2002. The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells. J. Immunol. 169(7):3519-25
17. Arinobu Y, Mizuno S, Chong Y, Shigematsu H, Iino T, et al. 2007. Reciprocal activation of GATA-1 and PU.1marks initial specification of hematopoietic stem cells into myeloerythroid andmyelolymphoid lineages. Cell Stem Cell 1(4):416-27
18. Ding L, Morrison SJ. 2013. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495(7440):231-35
19. Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW. 2002. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17(2):117-30
20. Lai AY, Kondo M. 2007. Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. PNAS 104(15):6311-16
21. Böiers C, Carrelha J, Lutteropp M, Luc S, Green JCA, et al. 2013. Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells. Cell Stem Cell 13(5):535-48
22. De Obaldia ME, Bell JJ, Bhandoola A. 2013. Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus. Blood 121(1):64-71
23. Zhang SL, Wang X, Manna S, Zlotoff DA, Bryson JL, et al. 2014. Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice. Blood 124(2):296-304
24. Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, et al. 2009. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 23(20):2376-81
25. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97(11):3333-41
26. Schlenner SM, Madan V, Busch K, Tietz A, Läufle C, et al. 2010. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 32(3):426-36
27. Dias S, Mansson R, Gurbuxani S, SigvardssonM, Kee BL. 2008. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29(2):217-27
28. Georgopoulos K, Bigby M, Wang JH, Molnar A,Wu P, et al. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79(1):143-56
29. Liu P, Keller JR, OrtizM, Tessarollo L, Rachel RA, et al. 2003. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4(6):525-32
30. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265(5178):1573-77
31. Gwin KA, Shapiro MB, Dolence JJ, Huang ZL, Medina KL. 2013. Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis. J. Immunol. 191(2):745-54
32. Zohren F, Souroullas GP, Luo M, Gerdemann U, Imperato MR, et al. 2012. The transcription factor Lyl-1 regulates lymphoid specification and themaintenance of earlyTlineage progenitors. Nat. Immunol. 13(8):761-69
33. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, et al. 2006. Stat5a/b are essential for normal lymphoid development and differentiation. PNAS 103(4):1000-5
34. Satoh Y, Yokota T, Sudo T, KondoM, Lai A, et al. 2013. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 38(6):1105-15
35. Dias S, Xu W, McGregor S, Kee B. 2008. Transcriptional regulation of lymphocyte development. Curr. Opin. Genet. Dev. 18(5):441-48
36. Ng SY-M, Yoshida T, Zhang J, Georgopoulos K. 2009. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30(4):493-507
37. Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R. 2005. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202(12):1669-77
38. Yang Q, Kardava L, St. Leger A, Martincic K, Varnum-Finney B, et al. 2008. E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J. Immunol. 181(9):5885-94
39. De Obaldia ME, Bell JJ, Wang X, Harly C, Yashiro-Ohtani Y, et al. 2013. T cell development requires constraint of the myeloid regulator C/EBP-αby the Notch target and transcriptional repressor Hes1. Nat. Immunol. 14(12):1277-84
40. Yang Q, Monticelli LA, Saenz SA, Chi AW-S, Sonnenberg GF, et al. 2013. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38(4):694-704
41. Laiosa CV, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T. 2006. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25(5):731-44
42. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117(5):663-76
43. Yang Q, Saenz SA, Zlotoff DA, Artis D, Bhandoola A. 2011. Cutting edge: Natural helper cells derive from lymphoid progenitors. J. Immunol. 187(11):5505-9
44. Possot C, Schmutz S, Chea S, Boucontet L, Louise A, et al. 2011. Notch signaling is necessary for adult, but not fetal, development of RORγt+ innate lymphoid cells. Nat. Immunol. 12(10):949-58
45. Spencer SP, Wilhelm C, YangQ,Hall JA, Bouladoux N, et al. 2014. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343(6169):432-37
46. Wong SH, Walker JA, Jolin HE,Drynan LF, Hams E, et al. 2012. Transcription factor RORαis critical for nuocyte development. Nat. Immunol. 13(3):229-36
47. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181(4):1519-26
48. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, et al. 2010. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 33(5):736-51
49. Wang JH,Nichogiannopoulou A,WuL, Sun L, Sharpe AH, et al. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5(6):537-49
50. Welner RS, Esplin BL, Garrett KP, Pelayo R, Luche H, et al. 2009. Asynchronous RAG-1 expression during B lymphopoiesis. J. Immunol. 183(12):7768-77
51. Karo JM, Schatz DG, Sun JC. 2014. TheRAGrecombinase dictates functional heterogeneity and cellular fitness in natural killer cells. Cell 159:94-107
52. Kuo TC, Schlissel MS. 2009. Mechanisms controlling expression of the RAG locus during lymphocyte development. Curr. Opin. Immunol. 21(2):173-78
53. Treiber T, Mandel EM, Pott S, Györy I, Firner S, et al. 2010. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription-independent poising of chromatin. Immunity 32(5):714-25
54. Nechanitzky R, Akbas D, Scherer S, Györy I, Hoyler T, et al. 2013. Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells. Nat. Immunol. 14(8):867-75
55. Banerjee A, Northrup D, Boukarabila H, Jacobsen SEW, Allman D. 2013. Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity 38(5):930-42
56. Souabni A, Cobaleda C, Schebesta M, Busslinger M. 2002. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17(6):781-93
57. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12(11):1045-54
58. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. 2010. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463(7280):540-44
59. Yokota Y, Mansouri A,Mori S, Sugawara S, Adachi S, et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397(6721):702-6
60. Eberl G, Marmon S, Sunshine M-J, Rennert PD, Choi Y, Littman DR. 2004. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5(1):64-73
61. Boos MD, Yokota Y, Eberl G, Kee BL. 2007. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204(5):1119-30
62. Carotta S, Pang SHM, Nutt SL, Belz GT. 2011. Identification of the earliest NK-cell precursor in the mouse BM. Blood 117(20):5449-52
63. Kee BL. 2009. E and ID proteins branch out. Nat. Rev. Immunol. 9(3):175-84
64. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. 2014. A committed precursor to innate lymphoid cells. Nature 508(7496):397-401
65. Yoshida H, Kawamoto H, Santee SM, Hashi H, Honda K, et al. 2001. Expression of α4β7 integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 167(5):2511-21
66. Mebius RE, Streeter PR, Michie S, Butcher EC, Weissman IL. 1996. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+CD3. cells to colonize lymph nodes. PNAS 93(20):11019-24
67. Mebius RE, Rennert P, Weissman IL. 1997. Developing lymph nodes collect CD4+CD3. LTβ+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7(4):493-504
68. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, et al. 2010. Lineage relationship analysis of RORγ+ innate lymphoid cells. Science 330(6004):665-69
69. Yu X, Wang Y, Deng M, Li Y, et al. 2014. The basic leucine zipper transcription factor NFIL3 directs the development of common innate lymphoid cell precursors. eLife 3:e04406
70. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, YiW, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9(9):1055-64
71. Savage AK, ConstantinidesMG, Han J, Picard D,Martin E, et al. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29(3):391-403
72. Raberger J, Schebesta A, Sakaguchi S, Boucheron N, Blomberg KEM, et al. 2008. The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. PNAS 105(46):17919-24
73. Kovalovsky D, Alonzo ES, Uche OU, Eidson M, Nichols KE, Sant'Angelo DB. 2010. PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals. J. Immunol. 184(12):6746-55
74. Mielke LA, Groom JR, Rankin LC, Seillet C, Masson F, et al. 2013. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation. J. Immunol. 191(8):4383-91
75. Bernink JH, Peters CP,Munneke M, te Velde AA, Meijer SL, et al. 2013. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14(3):221-29
76. Daussy C, Faure F,Mayol K, Viel S,Gasteiger G, et al. 2014. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp.Med. 211(3):563-77
77. Gordon SM, Chaix J, Rupp LJ,Wu J,Madera S, et al. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36(1):55-67
78. Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, et al. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105(5):2082-89
79. Kim S, Iizuka K, Kang HS, Dokun A, French AR, et al. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3(6):523-28
80. Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, et al. 2014. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157(2):340-56
81. Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee BL. 2013. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J. Immunol. 191(12):5973-83
82. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, et al. 2013. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-γ-producing cells. Immunity 38(4):769-81
83. Gascoyne DM, Long E, Veiga-Fernandes H, de Boer J, WilliamsO, et al. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10(10):1118-24
84. Kamizono S, Duncan GS, SeidelMG, Morimoto A, Hamada K, et al. 2009. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206(13):2977-86
85. Seillet C, Rankin LC, Groom JR,Mielke LA, Tellier J, et al. 2014. Nfil3 is required for the development of all innate lymphoid cell subsets. J. Exp. Med. 211(9):1733-40
86. Seillet C,HuntingtonND, Gangatirkar P, Axelsson E,Minnich M, et al. 2014. Differential requirement for Nfil3 during NK cell development. J. Immunol. 192(6):2667-76
87. Geiger TL, Abt MC,Gasteiger G, FirthMA, O'ConnorMH, et al. 2014. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211(9):1723-31
88. Crotta S, Gkioka A, Male V, Duarte JH, Davidson S, et al. 2014. The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development. J. Immunol. 192(6):2677-88
89. Cortez VS, Fuchs A, Cella M, Gilfillan S, Colonna M. 2014. Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state. J. Immunol. 192(10):4487-91
90. Firth MA, Madera S, Beaulieu AM, Gasteiger G, Castillo EF, et al. 2013. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J. Exp. Med. 210(13):2981-90
91. Kashiwada M, Cassel SL, Colgan JD, Rothman PB. 2011. NFIL3/E4BP4 controls type 2 T helper cell cytokine expression. EMBO J. 30(10):2071-82
92. Rothenberg EV. 2014. Transcriptional control of early T and B cell developmental choices. Annu. Rev. Immunol. 32:283-321
93. Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, et al. 2005. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat. Immunol. 6(7):663-70
94. Tan JB, Visan I, Yuan JS, Guidos CJ. 2005. Requirement for Notch1 signals at sequential early stages of intrathymic T cell development. Nat. Immunol. 6(7):671-79
95. Georgescu C, Longabaugh WJR, Scripture-Adams DD, David-Fung E-S, Yui MA, et al. 2008. A gene regulatory network armature for T lymphocyte specification. PNAS 105(51):20100-5
96. Maillard I, Tu L, Sambandam A, Yashiro-Ohtani Y, Millholland J, et al. 2006. The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J. Exp. Med. 203(10):2239-45
97. Reizis B, Leder P. 2002. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16(3):295-300
98. Allman D, Sambandam A, Kim S, Miller JP, Pagan A, et al. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4(2):168-74
99. Wu L, Antica M, Johnson GR, Scollay R, Shortman K. 1991. Developmental potential of the earliest precursor cells from the adult mouse thymus. J. Exp. Med. 174(6):1617-27
100. Wu L, Scollay R, Egerton M, Pearse M, Spangrude GJ, Shortman K. 1991. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 349(6304):71-74
101. Masuda K, Kakugawa K, Nakayama T, Minato N, Katsura Y, Kawamoto H. 2007. T cell lineage determination precedes the initiation of TCRβ gene rearrangement. J. Immunol. 179(6):3699-706
102. Taghon TN, David E-S, Zuiga-Pflucker JC, Rothenberg EV. 2005. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19(8):965.78
103. Constantinides MG, Bendelac A. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25(2):161.67
104. Bendelac A, Bonneville M, Kearney JF. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1(3):177.86
105. Lantz O, Bendelac A. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I.specific CD4+ and CD4.8. T cells in mice and humans. J. Exp.Med. 180(3):1097.106
106. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. 2013. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14(11):1146.54
107. WataraiH, Sekine-KondoE, ShigeuraT,Motomura Y, Yasuda T, et al. 2012. Development and function of invariant natural killer T cells producing TH2-and TH17-cytokines. PLOS Biol. 10(2):e1001255
108. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28:445.89
109. McDonald BD, Constantinides MG, Bendelac A. 2013. Polarized effector programs for innate-like thymocytes. Nat. Immunol. 14(11):1110.11
110. Terashima A, Watarai H, Inoue S, Sekine E, Nakagawa R, et al. 2008. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205(12):2727.33
111. Coquet JM, Chakravarti S, Kyparissoudis K,McNab FW, Pitt LA, et al. 2008. Diverse cytokine production byNKTcell subsets and identification of an IL-17.producing CD4.NK1.1. NKTcell population. PNAS 105(32):11287.92
112. Bezbradica JS,Hill T, Stanic AK, Van Kaer L, Joyce S. 2005. Commitment toward the naturalT(iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. PNAS 102(14):5114.19
113. Guo J, Hawwari A, Li H, Sun Z, Mahanta SK, et al. 2002. Regulation of the TCRα repertoire by the survival window of CD4+CD8+ thymocytes. Nat. Immunol. 3(5):469.76
114. Kim PJ, Pai S-Y, Brigl M, Besra GS, Gumperz J, Ho I-C. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177(10):6650.59
115. Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, et al. 1994. The nature of major histocompatibility complex recognition by γδT cells. Cell 76(1):29.37
116. Sciammas R, Bluestone JA. 1998. HSV-1 glycoprotein I-reactive TCRγδ cells directly recognize the peptide backbone in a conformationally dependent manner. J. Immunol. 161(10):5187.92
117. Weintraub BC, JacksonMR, Hedrick SM. 1994. Gamma delta T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J. Immunol. 153(7):3051.58
118. Azuara V, Levraud JP, Lembezat MP, Pereira P. 1997. A novel subset of adult γδ thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire. Eur. J. Immunol. 27(2):544.53
119. Jensen KD, Su X, Shin S, Li L, Youssef S, et al. 2008. Thymic selection determines γδ T cell effector fate: Antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29(1):90.100
120. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, et al. 2009. CD27 is a thymic determinant of the balance between interferon-δ-and interleukin 17-producing γδ T cell subsets. Nat. Immunol. 10(4):427.36
121. Narayan K, Sylvia KE, Malhotra N, Yin CC, Martens G, et al. 2012. Intrathymic programming of effector fates in three molecularly distinct γδT cell subtypes. Nat. Immunol. 13(5):511.18
122. Malhotra N, Narayan K, Cho OH, Sylvia KE, Yin C, et al. 2013. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38(4):681.93
123. Ardavin C,Wu L, Li CL, Shortman K. 1993. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362(6422):761.63
124. Cherrier M, Sawa S, Eberl G. 2012. Notch, Id2, and RORδt sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 209(4):729.40
125. Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, et al. 2008. Adult T-cell progenitors retain myeloid potential. Nature 452(7188):768-72
126. Bell JJ, Bhandoola A. 2008. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452(7188):764-67
127. Benz C, Bleul CC. 2005. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J. Exp. Med. 202(1):21-31
128. Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, et al. 2012. The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential. Nat. Immunol. 13(4):412-19
129. Schmitt TM, CiofaniM, Petrie HT, Zúñiga-Pflücker JC. 2004. Maintenance of T cell specification and differentiation requires recurrent Notch receptor-ligand interactions. J. Exp. Med. 200(4):469-79
130. García-OjedaME, KleinWolterink RGJ, Lematre F, Richard-Le Goff O, HasanM, et al. 2013.GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood 121(10):1749-59
131. Weber BN, Chi AW-S, Chavez A, Yashiro-Ohtani Y, Yang Q, et al. 2011. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476(7358):63-68
132. Feyerabend TB, Terszowski G, Tietz A, Blum C, Luche H, et al. 2009. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsicmechanisms. Immunity 30(1):67-79
133. Wilson A, MacDonald HR, Radtke F. 2001. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194(7):1003-12
134. Rothenberg EV, Zhang J, Li L. 2010. Multilayered specification of the T-cell lineage fate. Immunol. Rev. 238(1):150-68
135. Yui MA, Rothenberg EV. 2014. Developmental gene networks: a triathlon on the course to T cell identity. Nat. Rev. Immunol. 14(8):529-45
136. Ikawa T,Hirose S,Masuda K, Kakugawa K, Satoh R, et al. 2010. An essential developmental checkpoint for production of the T cell lineage. Science 329(5987):93-96
137. Li P, Burke S, Wang J, Chen X, Ortiz M, et al. 2010. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329(5987):85-89
138. Li J, Park J, Foss D, Goldschneider I. 2009. Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus. J. Exp. Med. 206(3):607-22
139. Ramond C, Berthault C, Burlen-Defranoux O, de Sousa AP, Guy-Grand D, et al. 2014. Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus. Nat. Immunol. 15(1):27-35
140. Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, et al. 2005. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRß chains than fetal progenitors. J. Immunol. 175(9):5848-56
141. Porritt HE, Rumfelt LL, Tabrizifard S, Schmitt TM, Zúñiga-Pflücker JC, Petrie HT. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20(6):735-45
142. Li L, Leid M, Rothenberg EV. 2010. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329(5987):89-93
143. Di Santo JP. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24:257-86
144. Di Santo JP, Vosshenrich CA. 2006. Bone marrow versus thymic pathways of natural killer cell development. Immunol. Rev. 214:35-46
145. Vosshenrich CAJ, García-OjedaME, Samson-Villéger SI, Pasqualetto V, Enault L, et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7(11):1217-24
146. HanssonM, Kärre K, Kiessling R, Roder J, Andersson B, Häyry P. 1979. Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population. J. Immunol. 123(2):765-71
147. Schott E, Bonasio R, Ploegh HL. 2003. Elimination in vivo of developing T cells by natural killer cells. J. Exp. Med. 198(8):1213-24
148. Koch U, Fiorini E, Benedito R, Besseyrias V, Schuster-Gossler K, et al. 2008. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp.Med. 205(11):2515-23
149. Fiorini E, Ferrero I, Merck E, Favre S, Pierres M, et al. 2008. Cutting edge: Thymic crosstalk regulates delta-like 4 expression on cortical epithelial cells. J. Immunol. 181(12):8199-203
150. RossiSW,Kim M-Y, Leibbrandt A, Parnell SM, JenkinsonWE, et al. 2007.RANKsignals fromCD4+3-inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp.Med. 204(6):1267-72
151. Dudakov JA, Hanash AM, Jenq RR, Young LF, Ghosh A, et al. 2012. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336(6077):91-95
152. Radtke F, Wilson A, Stark G, Bauer M, vanMeerwijk J, et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10(5):547-58
153. Maillard I,Weng AP, Carpenter AC, Rodriguez CG, Sai H, et al. 2004. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 104(6):1696-702
154. Lehar SM, Dooley J, Farr AG, Bevan MJ. 2005. Notch ligands Delta1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105(4):1440-47
155. Ikawa T, Kawamoto H, Goldrath AW, Murre C. 2006. E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment. J. Exp. Med. 203(5):1329-42
156. Hozumi K, Mailhos C, Negishi N, Hirano K, Yahata T, et al. 2008. Delta-like 4 is indispensable in thymic environment specific for T cell development. J. Exp. Med. 205(11):2507-13
157. Besseyrias V, Fiorini E, Strobl LJ, Zimber-Strobl U, Dumortier A, et al. 2007. Hierarchy ofNotch-Delta interactions promoting T cell lineage commitment and maturation. J. Exp. Med. 204(2):331-43
158. Yashiro-Ohtani Y, He Y, Ohtani T, Jones ME, Shestova O, et al. 2009. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. Genes Dev. 23(14):1665-76
159. Yu S, Xue H-H. 2013. TCF-1 mediates repression of Notch pathway in T lineage-committed early thymocytes. Blood 121(19):4008-9
160. Han W, Ye Q, Moore MA. 2000. A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 95(5):1616-25
161. Jones P, May G, Healy L, Brown J, Hoyne G, et al. 1998. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 92(5):1505-11
162. Radtke F, Wilson A, Mancini SJC,MacDonald HR. 2004. Notch regulation of lymphocyte development and function. Nat. Immunol. 5(3):247-53
163. SchmittTM, Zúñiga-Pflücker JC. 2002. Induction ofTcell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 17(6):749-56
164. Harman BC, Jenkinson WE, Parnell SM, Rossi SW, Jenkinson EJ, Anderson G. 2005. T/B lineage choice occurs prior to intrathymic Notch signaling. Blood 106(3):886-92
165. Yamaguchi E, Chiba S, Kumano K, Kunisato A, Takahashi T, et al. 2002. Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice. Immunol. Lett. 81(1):59-64
166. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117(4):515-26
167. Tanigaki K, HanH, YamamotoN,Tashiro K, IkegawaM, et al. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3(5):443-50
168. Tan JB, Xu K, Cretegny K, Visan I, Yuan JS, et al. 2009. Lunatic and Manic Fringe cooperatively enhance marginal zone B cell precursor competition for Delta-like 1 in splenic endothelial niches. Immunity 30(2):254-63
169. Schröder N, Gossler A. 2002. Expression of Notch pathway components in fetal and adult mouse small intestine. Gene Expr. Patterns 2(3-4):247-50
170. Hoyler T, Klose CSN, Souabni A, Turqueti-Neves A, Pfeifer D, et al. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37(4):634-48
171. Lee K, Nam KT, Cho SH, Gudapati P, Hwang Y, et al. 2012. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J. Exp. Med. 209(4):713-28
172. Perumalsamy LR, Marcel N, Kulkarni S, Radtke F, Sarin A. 2012. Distinct spatial andmolecular features of Notch pathway assembly in regulatory T cells. Sci. Signal. 5(234):ra53
173. PerumalsamyLR, Nagala M, Banerjee P, SarinA. 2009.Ahierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells. Cell Death Differ. 16(6):879-89
174. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, et al. 2012. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13(2):144.51
175. Rankin LC, Groom JR, Chopin M, Herold MJ, Walker JA, et al. 2013. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 14(4):389.95
176. Sciumle G, Hirahara K, Takahashi H, Laurence A, Villarino AV, et al. 2012. Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med. 209(13):2331.38
177. Izon DJ, Aster JC, He Y, Weng A, Karnell FG, et al. 2002. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 16(2):231.43
178. Yun TJ, Bevan MJ. 2003. Notch-regulated ankyrin-repeat protein inhibits Notch1 signaling: multiple Notch1 signaling pathways involved in T cell development. J. Immunol. 170(12):5834.41
179. Germar K, Dose M, Konstantinou T, Zhang J,Wang H, et al. 2011. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. PNAS 108(50):20060.65
180. Okamura RM, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. 1998. Redundant regulation of T cell differentiation and TCRαgene expression by the transcription factors LEF-1 and TCF-1. Immunity 8(1):11.20
181. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, et al. 1995. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374(6517):70.74
182. Goux D, Coudert JD, Maurice D, Scarpellino L, JeannetG, et al. 2005. Cooperating pre-T-cell receptor and TCF-1-dependent signals ensure thymocyte survival. Blood 106(5):1726.33
183. Schilham MW, Wilson A, Moerer P, Benaissa-Trouw BJ, Cumano A, Clevers HC. 1998. Critical involvement of Tcf-1 in expansion of thymocytes. J. Immunol. 161(8):3984.91
184. Yu S, Zhou X, Steinke FC, Liu C, Chen S-C, et al. 2012. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 37(5):813.26
185. Steinke FC, Xue H-H. 2014. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells. Immunol. Res. 59(1-3):45-55
186. Del Real MM, Rothenberg EV. 2013. Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3. Development 140(6):1207.19
187. Taghon T, Yui MA, Rothenberg EV. 2007. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat. Immunol. 8(8):845.55
188. Giese K, Pagel J, Grosschedl R. 1997. Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1. PNAS 94(24):12845.50
189. Gounari F, Aifantis I,Martin C, Fehling H-J, Hoeflinger S, et al. 2002. Tracing lymphopoiesis with the aid of a pTα-controlled reporter gene. Nat. Immunol. 3(5):489.96
190. CobasM,Wilson A, Ernst B,Mancini SJC,MacDonald HR, et al. 2004. Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199(2):221.29
191. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, et al. 2008. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood 111(1):142.49
192. Koch U, Wilson A, Cobas M, Kemler R, MacDonald HR, Radtke F. 2008. Simultaneous loss of betaand gamma-catenin does not perturb hematopoiesis or lymphopoiesis. Blood 111(1):160.64
193. Ohteki T, Wilson A, Verbeek S, MacDonald HR, Clevers H. 1996. Selectively impaired development of intestinal T cell receptor γδ+ cells and liver CD4+ NK1+ T cell receptor αβ+ cells in T cell factor-1-deficient mice. Eur. J. Immunol. 26(2):351.55
194. Yu Q, Sharma A, Oh SY, Moon H-G, Hossain MZ, et al. 2009. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat. Immunol. 10(9):992.99
195. Stock P, Lombardi V, Kohlrautz V, Akbari O. 2009. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J. Immunol. 182(8):5116.22
196. Held W, Clevers H, Grosschedl R. 2003. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur. J. Immunol. 33(5):1393.98
197. Held W, Kunz B, Lowin-Kropf B, van deWeteringM,CleversH. 1999. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 11(4):433.42
198. Hosoya T, Kuroha T, Moriguchi T, Cummings D,Maillard I, et al. 2009. GATA-3 is required for early T lineage progenitor development. J. Exp. Med. 206(13):2987.3000
199. Hozumi K, Negishi N, Tsuchiya I, Abe N, Hirano K, et al. 2008. Notch signaling is necessary for GATA3 function in the initiation of T cell development. Eur. J. Immunol. 38(4):977.85
200. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, et al. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11(1):40.44
201. Ting CN, Olson MC, Barton KP, Leiden JM. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384(6608):474.78
202. Pai S-Y, TruittML, Ting C-N, Leiden JM,Glimcher LH,Ho I-C. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19(6):863.75
203. Henderson AJ, McDougall S, Leiden J, Calame KL. 1994. GATA elements are necessary for the activity and tissue specificity of the T-cell receptor beta-chain transcriptional enhancer. Mol. Cell. Biol. 14(6):4286.94
204. Joulin V, Bories D, Elleouet JF, Labastie MC, Chrletien S, et al. 1991. A T-cell specific TCR delta DNA binding protein is a member of the human GATA family. EMBO J. 10(7):1809.16
205. Ko LJ, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD. 1991. Murine and human Tlymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol. Cell. Biol. 11(5):2778.84
206. Marine J, Winoto A. 1991. The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. PNAS 88(16):7284.88
207. Wei G, Abraham BJ, Yagi R, Jothi R, Cui K, et al. 2011. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35(2):299.311
208. Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV. 2012. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149(2):467. 82
209. Hernlandez-Hoyos G, Anderson MK, Wang C, Rothenberg EV, Alberola-Ila J. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19(1):83.94
210. Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, et al. 2008. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells. Nat. Immunol. 9(10):1122.30
211. Xu W, Carr T, Ramirez K, McGregor S, Sigvardsson M, Kee BL. 2013. E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment. Blood 121(9):1534.42
212. Pai S-Y, Truitt ML, Ho I-C. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. PNAS 101(7):1993.98
213. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, et al. 2004. Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses. Nat. Immunol. 5(11):1157.65
214. Yagi R, Zhong C, Northrup DL, Yu F, Bouladoux N, et al. 2014. The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells. Immunity 40(3):378.88
215. Wang Y, Misumi I, Gu A-D, Curtis TA, Su L, et al. 2013. GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling. Nat. Immunol. 14(7):714.22
216. Furusawa J, Moro K, Motomura Y, Okamoto K, Zhu J, et al. 2013. Critical role of p38 and GATA3 in natural helper cell function. J. Immunol. 191(4):1818.26
217. Liang H-E, Reinhardt RL, Bando JK, Sullivan BM, Ho I-C, Locksley RM. 2012. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat. Immunol. 13(1):58.66
218. Mjosberg JM, Trifari S, Crellin NK, Peters CP, vanDrunen CM, et al. 2011. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12(11):1055.62
219. SerafiniN,Klein Wolterink RGJ, Satoh-Takayama N, Xu W, Vosshenrich CAJ, et al. 2014. Gata3 drives development of RORαt+ group 3 innate lymphoid cells. J. Exp. Med. 211(2):199.208
220. Hock H, Orkin SH. 2006. Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells. Curr. Opin. Hematol. 13(1):1-6
221. Zeng H, Yücel R, Kosan C, Klein-Hitpass L, Möröy T. 2004. Transcription factor Gfi1 regulates selfrenewal and engraftment of hematopoietic stem cells. EMBO J. 23(20):4116-25
222. Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, et al. 2003. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 18(1):109-20
223. Yücel R, Karsunky H, Klein-Hitpass L, Möröy T. 2003. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J. Exp. Med. 197(7):831-44
224. Yücel R, Kosan C, Heyd F, Möröy T. 2004. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development. J. Biol. Chem. 279(39):40906-17
225. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. 1993. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell. Biol. 13(3):1759-68
226. Zhu J, Guo L, Min B, Watson CJ, Hu-Li J, et al. 2002. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 16(5):733-44
227. Pargmann D, Yücel R, Kosan C, Saba I, Klein-Hitpass L, et al. 2007. Differential impact of the transcriptional repressorGfi1 on mature CD4+ andCD8+ Tlymphocyte function. Eur. J. Immunol. 37(12):3551-63
228. Zhu J, Davidson TS, Wei G, Jankovic D, Cui K, et al. 2009. Down-regulation of Gfi-1 expression by TGF-βis important for differentiation of Th17 and CD103+ inducible regulatory T cells. J. Exp. Med. 206(2):329-41
229. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE. 2006. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. PNAS 103(48):18214-19
230. Shinnakasu R, Yamashita M, Kuwahara M, Hosokawa H, Hasegawa A, et al. 2008. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J. Biol. Chem. 283(42):28216-25
231. Spooner CJ, Lesch J, Yan D, Khan AA, Abbas A, et al. 2013. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat. Immunol. 14(12):1229-36
232. Marks BR, Nowyhed HN, Choi J-Y, Poholek AC, Odegard JM, et al. 2009. Thymic self-reactivity selects natural interleukin 17-producingTcells that can regulate peripheral inflammation. Nat. Immunol. 10(10):1125-32
233. Tanaka S, Yoshimoto T, Naka T, Nakae S, Iwakura Y-I, et al. 2009. Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J. Immunol. 183(11):7523-30
234. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, et al. 1997. E2A deficiency leads to abnormalities in αβT-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17(8):4782-91
235. YanW, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y. 1997. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17(12):7317-27
236. Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C. 2001. Regulation of the helixloop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2(2):165-71
237. Engel I, Johns C, Bain G, Rivera RR, Murre C. 2001. Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194(6):733-45
238. Jones-MasonME, Zhao X, Kappes D, Lasorella A, Iavarone A, Zhuang Y. 2012. E protein transcription factors are required for the development of CD4+ lineage T cells. Immunity 36(3):348-61
239. Barndt R, Dai MF, Zhuang Y. 1999. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis. J. Immunol. 163(6):3331-43
240. Wojciechowski J, Lai A, Kondo M, Zhuang Y. 2007. E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. J. Immunol. 178(9):5717-26
241. Braunstein M, Anderson MK. 2010. Developmental progression of fetal HEB-/- precursors to the pre-T-cell stage is restored by HEBAlt. Eur. J. Immunol. 40(11):3173-82
242. Braunstein M, Anderson MK. 2012. HEB in the spotlight: transcriptional regulation of T-cell specification, commitment, and developmental plasticity. Clin. Dev. Immunol. 2012:678705
243. Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G. 1999. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36(8):491.503
244. Kastner P, Chan S, Vogel WK, Zhang L-J, Topark-Ngarm A, et al. 2010. Bcl11b represses a mature T-cell gene expression program in immature CD4+CD8+ thymocytes. Eur. J. Immunol. 40(8):2143.54
245. Zhang B, Lin Y-Y, DaiM, Zhuang Y. 2014. Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδT cells. J. Immunol. 192(3):1055.63
246. Cannarile MA, Lind NA, Rivera R, Sheridan AD, Camfield KA, et al. 2006. Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat. Immunol. 7(12):1317.25
247. Yang CY, Best JA, Knell J, Yang E, Sheridan AD, et al. 2011. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat. Immunol. 12(12):1221.29
248. Kreslavsky T, Savage AK, Hobbs R, Gounari F, Bronson R, et al. 2009. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of γδT cells with restricted TCR diversity. PNAS 106(30):12453.58
249. Aliahmad P, de la Torre B, Kaye J. 2010. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 11(10):945.52
250. Male V, Nisoli I, KostrzewskiT, Allan DSJ, Carlyle JR, et al. 2014. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression. J. Exp. Med. 211(4):635.42
251. Yu X, Rollins D, Ruhn KA, Stubblefield JJ, Green CB, et al. 2013. TH17 cell differentiation is regulated by the circadian clock. Science 342(6159):727.30
252. Zhang W, Zhang J, Kornuc M, Kwan K, Frank R, Nimer SD. 1995. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol. Cell. Biol. 15(11):6055.63
253. Motomura Y, Kitamura H, Hijikata A, Matsunaga Y,Matsumoto K, et al. 2011. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat. Immunol. 12(5):450.59
254. Liu P, Li P, Burke S. 2010. Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol. Rev. 238(1):138.49
255. Wakabayashi Y,Watanabe H, Inoue J, Takeda N, Sakata J, et al. 2003. Bcl11b is required for differentiation and survival of αβT lymphocytes. Nat. Immunol. 4(6):533.39
256. Albu DI, Feng D, Bhattacharya D, Jenkins NA, Copeland NG, et al. 2007. BCL11B is required for positive selection and survival of double-positive thymocytes. J. Exp. Med. 204(12):3003.15
257. Giguère V. 1999. Orphan nuclear receptors: from gene to function. Endocr. Rev. 20(5):689.725
258. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song S-Y. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21(4):527.38
259. Mora JR, Iwata M, Eksteen B, Song S-Y, Junt T, et al. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314(5802):1157.60
260. Hall JA, Cannons JL, Grainger JR, Dos Santos LM, Hand TW, et al. 2011. Essential role for retinoic acid in the promotion of CD4+ T cell effector responses via retinoic acid receptor alpha. Immunity 34(3):435.47
261. Coombes JL, Siddiqui KRR, Arancibia-Clarcamo CV, Hall J, Sun C-M, et al. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β. and retinoic acid.dependent mechanism. J. Exp. Med. 204(8):1757.64
262. Denning TL,Wang Y, Patel SR,Williams IR, Pulendran B. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8(10):1086.94
263. SunC-M,Hall JA, BlankRB, Bouladoux N, Oukka M, et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204(8):1775.85
264. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, et al. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111(3):1013.20
265. Hill JA, Hall JA, Sun C-M, Cai Q, Ghyselinck N, et al. 2008. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29(5):758.70
266. He YW, Beers C, DeftosML, Ojala EW, Forbush KA, BevanMJ. 2000. Down-regulation of the orphan nuclear receptor RORγt is essential for T lymphocyte maturation. J. Immunol. 164(11):5668-74
267. Sun Z, Unutmaz D, Zou YR, SunshineMJ, Pierani A, et al. 2000. Requirement for RORγin thymocyte survival and lymphoid organ development. Science 288(5475):2369-73
268. Kurebayashi S,Ueda E, SakaueM, Patel DD, Medvedev A, et al. 2000. Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. PNAS 97(18):10132-37
269. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. 2006. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121-33
270. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317(5835):256-60
271. Sundrud MS, Rao A. 2008. Regulation of T helper 17 differentiation by orphan nuclear receptors: It's not just RORγt anymore. Immunity 28(1):5-7
272. Yang XO, Pappu BP,Nurieva R, Akimzhanov A, Kang HS, et al. 2008.Thelper 17 lineage differentiation is programmed by orphan nuclear receptors RORαand RORγ. Immunity 28(1):29-39
273. Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, et al. 2013. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210(6):1117-24
274. Van de Pavert SA, Ferreira M, Domingues RG, Ribeiro H, Molenaar R, et al. 2014. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508(7494):123-27
275. Halim TYF, MacLaren A, Romanish MT, Gold MJ, McNagny KM, Takei F. 2012. Retinoic-acidreceptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37(3):463-74
276. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, et al. 2009. RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10(1):83-91
277. Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, et al. 2009. Influence of the transcription factor RORγt on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10(1):75-82
278. Eberl G, Littman DR. 2003. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195:81-90
279. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30(1):92-107
280. Satoh-Takayama N, Vosshenrich CAJ, Lesjean-Pottier S, Sawa S, Lochner M, et al. 2008. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29(6):958-70
281. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, et al. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473(7345):43-49
282. Bulger M, Groudine M. 2011. Functional and mechanistic diversity of distal transcription enhancers. Cell 144(3):327-39
283. Kieffer-Kwon K-R, Tang Z, Mathe E, Qian J, Sung M-H, et al. 2013. Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell 155(7):1507-20
284. Natoli G. 2010. Maintaining cell identity through global control of genomic organization. Immunity 33(1):12-24
285. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, et al. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447(7146):799-816
286. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39(3):311-18
287. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459(7243):108-12
288. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, et al. 2010. ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 42(9):806-10
289. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. PNAS 107(50):21931-36
290. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32(3):317-28
291. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470(7333):279-83
292. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457(7231):854-58
293. Wang D, Garcia-Bassets I, Benner C, LiW, Su X, et al. 2011. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474(7351):390-94
294. Lara-AstiasoD,Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, et al. 2014. Chromatin state dynamics during blood formation. Science 345(6199):943-49
295. Ciofani M, Madar A, Galan C, Sellars M, Mace K, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151(2):289-303
296. Vahedi G, Takahashi H, Nakayamada S, Sun H-W, Sartorelli V, et al. 2012. STATs shape the active enhancer landscape of T cell populations. Cell 151(5):981-93
297. Samstein RM, Arvey A, Josefowicz SZ, Peng X, Reynolds A, et al. 2012. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151(1):153-66
298. Ouyang W, Liao W, Luo CT, Yin N, Huse M, et al. 2012. Novel Foxo1-dependent transcriptional programs control Treg cell function. Nature 491(7425):554-59
299. Kawamoto H, IkawaT,Masuda K, Wada H, Katsura Y. 2010.Amap for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based model. Immunol. Rev. 238(1):23-36
300. Kärre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 391:675-78
301. Hepworth MR, Sonnenberg GF. 2014. Regulation of the adaptive immune system by innate lymphoid cells. Curr. Opin. Immunol. 27:75-82
302. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15(6):985-95
303. Hurst SD, Muchamuel T,GormanDM, Gilbert JM, Clifford T, et al. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169(1):443-53
304. Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, et al. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. 203(4):1105-16
305. Neill DR,Wong SH, Bellosi A, Flynn RJ, Daly M, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464(7293):1367-70
306. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, et al. 2010. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. PNAS 107(25):11489-94
307. TachibanaM,Tenno M, Tezuka C, Sugiyama M, YoshidaH,Taniuchi I. 2011. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages. J. Immunol. 186(3):1450-57
308. Kim MY, Rossi S, Withers D, McConnell F, Toellner KM, et al. 2008. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 124(2):166-74
309. Takatori H, Kanno Y, Watford WT, Tato CM,Weiss G, et al. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206(1):35-41
310. Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, et al. 2010. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med. 207(2):273-80
311. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. 2011. CD4+ lymphoid tissue inducer cells promote innate immunity in the gut. Immunity 34(1):122-34
312. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, et al. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464(7293):1371-75
313. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, et al. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457(7230):722-25